Surgical Science: More realistic targets, will need to regain investor confidence - Redeye

Redeye updates its estimates and valuation after Surgical Science’s capital markets day. We endorse the company’s focus on improving profitability outside of robotics and a relisting enabling potential buybacks. Still, we suspect that operational improvements and regaining investor confidence will take some time, with recent news around Intuitive and da Vinci 5 attach rate creating significant uncertainty.

Länk till analysen i sin helhet: https://www.redeye.se/research/1143128/surgical-science-more-realistic-targets-will-need-to-regain-investor-confidence?utm_source=finwire&utm_medium=RSS